Cargando…

Reciprocal regulatory mechanism between miR-214-3p and FGFR1 in FGFR1-amplified lung cancer

MicroRNA (miRNA) and fibroblast growth factor receptor 1 (FGFR1) dysregulation are considered to play an important role in tumor proliferation, invasion, and metastasis. However, the regulatory mechanism between miRNAs and FGFR1 in lung cancer remains unclear and extremely critical. miR-214-3p was s...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Ying, Li, Ziming, Yuan, Hong, Ji, Wenxiang, Wang, Kaixuan, Lu, Tingting, Yu, Yongfeng, Zeng, Qingyu, Li, Fan, Xia, Weiliang, Lu, Shun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731303/
https://www.ncbi.nlm.nih.gov/pubmed/31492847
http://dx.doi.org/10.1038/s41389-019-0151-1
_version_ 1783449663441993728
author Yang, Ying
Li, Ziming
Yuan, Hong
Ji, Wenxiang
Wang, Kaixuan
Lu, Tingting
Yu, Yongfeng
Zeng, Qingyu
Li, Fan
Xia, Weiliang
Lu, Shun
author_facet Yang, Ying
Li, Ziming
Yuan, Hong
Ji, Wenxiang
Wang, Kaixuan
Lu, Tingting
Yu, Yongfeng
Zeng, Qingyu
Li, Fan
Xia, Weiliang
Lu, Shun
author_sort Yang, Ying
collection PubMed
description MicroRNA (miRNA) and fibroblast growth factor receptor 1 (FGFR1) dysregulation are considered to play an important role in tumor proliferation, invasion, and metastasis. However, the regulatory mechanism between miRNAs and FGFR1 in lung cancer remains unclear and extremely critical. miR-214-3p was sharply decreased and showed a significantly negative correlation with FGFR1 in lung cancer patients (n = 30). Luciferase reporter assay confirmed that miR-214-3p could downregulate FGFR1 by directly targeting 3′-untranslated region (UTR). miR-214-3p inhibited the processes of epithelial–mesenchymal transition and Wnt/MAPK/AKT (Wnt/mitogen-activated protein kinase/AKT) signaling pathway by targeting FGFR1. Moreover, miR-214-3p not only established a negative feedback regulation loop with FGFR1 through ERK (extracellular signal-regulated kinase) but also developed a synergism with FGFR1 inhibitor AZD4547. In conclusion, our study demonstrated the regulatory mechanism between miR-214-3p and FGFR1 in lung cancer. miR-214-3p acts as a vital target in FGFR1-amplified lung cancer by forming a miR-214-3p-FGFR1-Wnt/MAPK/AKT signaling pathway network. Co-targeting miR-214-3p and FGFR1 could provide greater benefits to patients with FGFR1-amplified lung cancer.
format Online
Article
Text
id pubmed-6731303
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-67313032019-09-09 Reciprocal regulatory mechanism between miR-214-3p and FGFR1 in FGFR1-amplified lung cancer Yang, Ying Li, Ziming Yuan, Hong Ji, Wenxiang Wang, Kaixuan Lu, Tingting Yu, Yongfeng Zeng, Qingyu Li, Fan Xia, Weiliang Lu, Shun Oncogenesis Article MicroRNA (miRNA) and fibroblast growth factor receptor 1 (FGFR1) dysregulation are considered to play an important role in tumor proliferation, invasion, and metastasis. However, the regulatory mechanism between miRNAs and FGFR1 in lung cancer remains unclear and extremely critical. miR-214-3p was sharply decreased and showed a significantly negative correlation with FGFR1 in lung cancer patients (n = 30). Luciferase reporter assay confirmed that miR-214-3p could downregulate FGFR1 by directly targeting 3′-untranslated region (UTR). miR-214-3p inhibited the processes of epithelial–mesenchymal transition and Wnt/MAPK/AKT (Wnt/mitogen-activated protein kinase/AKT) signaling pathway by targeting FGFR1. Moreover, miR-214-3p not only established a negative feedback regulation loop with FGFR1 through ERK (extracellular signal-regulated kinase) but also developed a synergism with FGFR1 inhibitor AZD4547. In conclusion, our study demonstrated the regulatory mechanism between miR-214-3p and FGFR1 in lung cancer. miR-214-3p acts as a vital target in FGFR1-amplified lung cancer by forming a miR-214-3p-FGFR1-Wnt/MAPK/AKT signaling pathway network. Co-targeting miR-214-3p and FGFR1 could provide greater benefits to patients with FGFR1-amplified lung cancer. Nature Publishing Group UK 2019-09-06 /pmc/articles/PMC6731303/ /pubmed/31492847 http://dx.doi.org/10.1038/s41389-019-0151-1 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Yang, Ying
Li, Ziming
Yuan, Hong
Ji, Wenxiang
Wang, Kaixuan
Lu, Tingting
Yu, Yongfeng
Zeng, Qingyu
Li, Fan
Xia, Weiliang
Lu, Shun
Reciprocal regulatory mechanism between miR-214-3p and FGFR1 in FGFR1-amplified lung cancer
title Reciprocal regulatory mechanism between miR-214-3p and FGFR1 in FGFR1-amplified lung cancer
title_full Reciprocal regulatory mechanism between miR-214-3p and FGFR1 in FGFR1-amplified lung cancer
title_fullStr Reciprocal regulatory mechanism between miR-214-3p and FGFR1 in FGFR1-amplified lung cancer
title_full_unstemmed Reciprocal regulatory mechanism between miR-214-3p and FGFR1 in FGFR1-amplified lung cancer
title_short Reciprocal regulatory mechanism between miR-214-3p and FGFR1 in FGFR1-amplified lung cancer
title_sort reciprocal regulatory mechanism between mir-214-3p and fgfr1 in fgfr1-amplified lung cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731303/
https://www.ncbi.nlm.nih.gov/pubmed/31492847
http://dx.doi.org/10.1038/s41389-019-0151-1
work_keys_str_mv AT yangying reciprocalregulatorymechanismbetweenmir2143pandfgfr1infgfr1amplifiedlungcancer
AT liziming reciprocalregulatorymechanismbetweenmir2143pandfgfr1infgfr1amplifiedlungcancer
AT yuanhong reciprocalregulatorymechanismbetweenmir2143pandfgfr1infgfr1amplifiedlungcancer
AT jiwenxiang reciprocalregulatorymechanismbetweenmir2143pandfgfr1infgfr1amplifiedlungcancer
AT wangkaixuan reciprocalregulatorymechanismbetweenmir2143pandfgfr1infgfr1amplifiedlungcancer
AT lutingting reciprocalregulatorymechanismbetweenmir2143pandfgfr1infgfr1amplifiedlungcancer
AT yuyongfeng reciprocalregulatorymechanismbetweenmir2143pandfgfr1infgfr1amplifiedlungcancer
AT zengqingyu reciprocalregulatorymechanismbetweenmir2143pandfgfr1infgfr1amplifiedlungcancer
AT lifan reciprocalregulatorymechanismbetweenmir2143pandfgfr1infgfr1amplifiedlungcancer
AT xiaweiliang reciprocalregulatorymechanismbetweenmir2143pandfgfr1infgfr1amplifiedlungcancer
AT lushun reciprocalregulatorymechanismbetweenmir2143pandfgfr1infgfr1amplifiedlungcancer